• CellaVision will hold an extraordinary general meeting in Lund on Sept. 2, 2026.
• Shareholders will vote on an Employee Option Program 2026 for the CEO covering up to 100,000 employee options.
• The options would carry an exercise price set at 150% of the 10-day volume-weighted average share price before the meeting.
• The meeting will also consider a directed issue of up to 100,000 warrants to support share delivery under the program, implying about 0.42% dilution if fully exercised.
• Shareholders will also elect Ola Grahn as chair of the meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CellaVision AB published the original content used to generate this news brief on August 07, 2026, and is solely responsible for the information contained therein.